A Large-scale and Extensible Platform for Precision Medicine Research

被引:0
|
作者
Belghait, Fodil [1 ]
April, Alain [1 ]
Hamet, Pavel [2 ]
Tremblay, Johanne [2 ]
Desrosiers, Christian [1 ]
机构
[1] Ecole Technol Super, 1100 Notre Dame West, Montreal, PQ, Canada
[2] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
来源
PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON DIGITAL PUBLIC HEALTH (DPH '19) | 2019年
关键词
Clinical Databases; Genomics; Precision medicine; Bioinformatics; Big Data; ADVANCE; DISEASE;
D O I
10.1145/3357729.3357742
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
The massive adoption of high-throughput genomics, deep sequencing technologies and big data technologies have made possible the era of precision medicine. However, the volume of data and its complexity remain important challenges for precision medicine research, hindering development in this field. The literature on precision medicine research describes a few platforms to support specific types of studies, but none of these offer researchers the level of customization required to meet their specific needs [1]. Methods: We propose to design and develop a platform able to import and integrate a very large volume of genetics, clinical, demographical and environmental data in a cloud computing infrastructure. In our previous publication, we presented an approach that can customize existing data models to fit any precision medicine research data requirement [1] and the requirement for future large-scale precision medicine platforms, in terms of data extensibility and the scalability of processing on demand. We also proposed a framework to meet the specific requirement of any precision medicine research [2]. In this paper, we describe how this new framework was implemented and trialed by the precision medicine researchers at the Centre Hospitalier Universitaire de l'Universite de Montreal (CHUM). Results: The data analysis simulations showed that the random forest algorithm presents better accuracy results. We obtained an F1-Score of 72% for random forest, 69% using linear regression and 62% using the neural network algorithm. Conclusion: The results suggest that the proposed precision medicine data analysis platform allows researchers to configure, prepare the analysis environment and customize the platform data model to their specific research in very optimal delays, at very low cost and with minimal technical skills.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [21] Inquire: Large-scale Early Insight Discovery for Qualitative Research
    Paredes, Pablo
    Ferreira, Ana Rufino
    Schillaci, Cory
    Yoo, Gene
    Karashchuk, Pierre
    Xing, Dennis
    Cheshire, Coye
    Canny, John
    CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, 2017, : 1562 - 1575
  • [22] G-DOC Plus - an integrative bioinformatics platform for precision medicine
    Bhuvaneshwar, Krithika
    Belouali, Anas
    Singh, Varun
    Johnson, Robert M.
    Song, Lei
    Alaoui, Adil
    Harris, Michael A.
    Clarke, Robert
    Weiner, Louis M.
    Gusev, Yuriy
    Madhavan, Subha
    BMC BIOINFORMATICS, 2016, 17
  • [23] Construction and optimization of multi-platform precision pathways for precision medicine
    Tran, Andy
    Wang, Andy
    Mickaill, Jamie
    Strbenac, Dario
    Larance, Mark
    Vernon, Stephen T.
    Grieve, Stuart M.
    Figtree, Gemma A.
    Patrick, Ellis
    Yang, Jean Yee Hwa
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [24] Marginalized measures: The harmonization of diversity in precision medicine research
    Jeske, Melanie
    Saperstein, Aliya
    Lee, Sandra Soo-Jin
    Shim, Janet K.
    SOCIAL STUDIES OF SCIENCE, 2025, 55 (02) : 178 - 208
  • [25] Global Inequities in Precision Medicine and Molecular Cancer Research
    Drake, Thomas M.
    Knight, Stephen R.
    Harrison, Ewen M.
    Soreide, Kjetil
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [26] Diagnostics for personalized medicine: what will change in the era of large-scale genomics studies?
    Grewal, Anoop
    Stephan, Dietrich A.
    PERSONALIZED MEDICINE, 2013, 10 (08) : 835 - 848
  • [27] Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information
    Ryuji Hamamoto
    Takafumi Koyama
    Nobuji Kouno
    Tomohiro Yasuda
    Shuntaro Yui
    Kazuki Sudo
    Makoto Hirata
    Kuniko Sunami
    Takashi Kubo
    Ken Takasawa
    Satoshi Takahashi
    Hidenori Machino
    Kazuma Kobayashi
    Ken Asada
    Masaaki Komatsu
    Syuzo Kaneko
    Yasushi Yatabe
    Noboru Yamamoto
    Experimental Hematology & Oncology, 11
  • [28] Large-scale, pragmatic randomized trials in the era of big data, precision medicine and machine learning. Valid and necessary, or outdated and a waste of resources?
    Stengel, Dirk
    Augat, Peter
    Giannoudis, Peter V.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2023, 54 : S2 - S9
  • [29] Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
    Feng, Fangyoumin
    Shen, Bihan
    Mou, Xiaoqin
    Li, Yixue
    Li, Hong
    JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (07) : 540 - 551
  • [30] Precision medicine path at personalized medicine research center/endocrinology and metabolism research institute: A systematic review
    Sarhangi, Negar
    Nikfar, Shekoufeh
    Hasanzad, Mandana
    Larijani, Bagher
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (02) : 1507 - 1513